Bixiye
P56-16 A New Drug, Dupilumab Will Require Prior Authorization
Taariikhda uu dhaqangalayo Barnaamijka: Nov 22, 2016
Natiijooyinka Raadinta
Soo bandhiga 3081 - 3090 ee natiijooyinka 4130
Bixiye
P4-17 Addition of Drug to the Self-Administered Oncology Prior Authorization with Quantity Limit Program
Taariikhda uu dhaqangalayo Barnaamijka: Jan 30, 2017
Bixiye
P64-17 New Drug-Related PA with Quantity Limit Criteria: Biologic Immunomodulators
Taariikhda uu dhaqangalayo Barnaamijka: Nov 06, 2017
Bixiye
P13-18 Commercial and FEP Business New Reimbursement Policy for Facility: Readmission
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P68-17 Reimbursement Rate Changes for Psychotherapy Codes 90837 and 90838
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2017
Bixiye
P30-17 New Drug-Related Prior Authorization (PA) Criteria: Topical Retinoids
Taariikhda wax ku ool ah ee barnaamijka: Jun 05, 2017
Bixiye
P41-18 Update: Change to TPA Business
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 04, 2018
Bixiye
P46-17 Addition of Drug to the Self-Administered Oncology PA with Quantity Limit Program
Taariikhda barnaamijka Dhaqangalayso Agosto 14, 2017
Bixiye
P12-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective June 4, 2018
Taariikhda uu dhaqangalayo Barnaamijka: : Abr 02, 2018
Bixiye
P10-18 Blue Cross Will Cease Mailing Certain Provider Bulletins
Taariikhda uu dhaqangalayo Barnaamijka: Mar 01, 2018